<p>Carmell Co.（納斯達克代碼：CTCX - 獲取免費報告）週四股價下跌了 2.8%。該股最低交易價為$2.38，最後交易價為$2.45。在交易過程中，約有 18,767 股成交，較平均每日成交量 4,290,529 股下降了 100%。該股此前收盤價為$2.52。</p>
<h2>Carmell 股票表現</h2>
<p>該公司的 50 日移動平均價為$2.05，200 日移動平均價為$0.89。</p>
<h2>Carmell 的機構交易</h2>
<p>一家對沖基金最近在 Carmell 股票中購買了新股份。根據該公司在最近向 SEC 提交的 13F 文件，Citadel Advisors LLC 在第四季度購買了 Carmell Co.（納斯達克代碼：CTCX - 免費報告）的新股份。該機構投資者購買了 187,565 股公司股票，價值約為$54,000。截至最近的 SEC 文件，Citadel Advisors LLC 持有 Carmell 的 0.90%。機構投資者持有該公司 24.22% 的股份。</p>
<h2>關於 Carmell</h2>
<p>（獲取免費報告）</p>
<p>Carmell Corporation 是一家生物美學公司。該公司利用 Carmell Secretome 來支持皮膚和頭髮健康。其 Carmell Secretome 由從組織庫提取的同種異體人血小板中的生長因子和蛋白質組成。該公司還開發了一種微乳液配方，使得在不依賴於常用於賦予化妝品質感、穩定性和其他理想物理化學特性的 14 種潛在有害輔料的情況下，能夠傳遞親脂性和親水性成分。</p>
<h2>瞭解更多</h2>
<ul>
<li>五隻我們更看好的股票比 Carmell 更好</li>
<li>英國市場假期是什麼？如何投資和交易</li>
<li>Rigetti Computing：Cantor 的看漲呼聲可能只是開始</li>
<li>工業產品股票投資</li>
<li>大型銀行回購：摩根士丹利、花旗和富國銀行領先</li>
<li>如何投資最佳加拿大股票</li>
<li>3 只低於$20 的頂級股票，乘着 “美國製造” 的浪潮</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資$1,000 在 Carmell 嗎？</h2>
<p>在考慮 Carmell 之前，你會想聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Carmell 並不在名單上。</p>
<p>雖然 Carmell 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

CTCX

<p>Carmell Co.（納斯達克代碼：CTCX）股價下跌 2.8%，至 2.45 美元，交易量顯著下降至 18,767 股，而平均交易量為 4,290,529 股。機構持股比例為 24.22%，Citadel Advisors 最近收購了該公司的股份。該公司專注於生物美學，利用人類血小板中的生長因子促進皮膚和頭髮健康。分析師目前對 Carmell 的評級為持有，但建議其他股票可能是更好的投資選擇</p>

<p>Carmell Co. (NASDAQ:CTCX - Get Free Report)'s stock price dropped 2.8% on Thursday . The stock traded as low as $2.38 and last traded at $2.45. Approximately 18,767 shares traded hands during trading, a decline of 100% from the average daily volume of 4,290,529 shares. The stock had previously closed at $2.52.</p>
<div class="lb-trans"><p>Carmell Co.（納斯達克代碼：CTCX - 獲取免費報告）週四股價下跌了 2.8%。該股最低交易價為$2.38，最後交易價為$2.45。在交易過程中，約有 18,767 股成交，較平均每日成交量 4,290,529 股下降了 100%。該股此前收盤價為$2.52。</p>
</div><h2>Carmell Stock Performance</h2>
<div class="lb-trans"><h2>Carmell 股票表現</h2>
</div><p>The firm has a 50 day moving average of $2.05 and a two-hundred day moving average of $0.89.</p>
<div class="lb-trans"><p>該公司的 50 日移動平均價為$2.05，200 日移動平均價為$0.89。</p>
</div><h2>Institutional Trading of Carmell</h2>
<div class="lb-trans"><h2>Carmell 的機構交易</h2>
</div><p>A hedge fund recently bought a new stake in Carmell stock. Citadel Advisors LLC bought a new stake in shares of Carmell Co. (NASDAQ:CTCX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 187,565 shares of the company's stock, valued at approximately $54,000. Citadel Advisors LLC owned 0.90% of Carmell as of its most recent SEC filing. Institutional investors own 24.22% of the company's stock.</p>
<div class="lb-trans"><p>一家對沖基金最近在 Carmell 股票中購買了新股份。根據該公司在最近向 SEC 提交的 13F 文件，Citadel Advisors LLC 在第四季度購買了 Carmell Co.（納斯達克代碼：CTCX - 免費報告）的新股份。該機構投資者購買了 187,565 股公司股票，價值約為$54,000。截至最近的 SEC 文件，Citadel Advisors LLC 持有 Carmell 的 0.90%。機構投資者持有該公司 24.22% 的股份。</p>
</div><h2>About Carmell</h2>
<div class="lb-trans"><h2>關於 Carmell</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.</p>
<div class="lb-trans"><p>Carmell Corporation 是一家生物美學公司。該公司利用 Carmell Secretome 來支持皮膚和頭髮健康。其 Carmell Secretome 由從組織庫提取的同種異體人血小板中的生長因子和蛋白質組成。該公司還開發了一種微乳液配方，使得在不依賴於常用於賦予化妝品質感、穩定性和其他理想物理化學特性的 14 種潛在有害輔料的情況下，能夠傳遞親脂性和親水性成分。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than Carmell</li>
<li>What Are the U.K. Market Holidays? How to Invest and Trade</li>
<li>Rigetti Computing: Cantor's Bullish Call May Be Just the Start</li>
<li>Industrial Products Stocks Investing</li>
<li>Big Bank Buybacks: Morgan Stanley, Citi, &amp; Wells Fargo Lead</li>
<li>How to Invest in the Best Canadian Stocks</li>
<li>3 Top Stocks Under $20 Riding the “Made in America” Wave</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票比 Carmell 更好</li>
<li>英國市場假期是什麼？如何投資和交易</li>
<li>Rigetti Computing：Cantor 的看漲呼聲可能只是開始</li>
<li>工業產品股票投資</li>
<li>大型銀行回購：摩根士丹利、花旗和富國銀行領先</li>
<li>如何投資最佳加拿大股票</li>
<li>3 只低於$20 的頂級股票，乘着 “美國製造” 的浪潮</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Carmell Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 在 Carmell 嗎？</h2>
</div><p>Before you consider Carmell, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Carmell 之前，你會想聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Carmell wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Carmell 並不在名單上。</p>
</div><p>While Carmell currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Carmell 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Carmell (NASDAQ:CTCX) 股價下跌 2.8% - 以下是原因